Sanara MedTech Profit Margin

The latest profit margin for SMTI is -29.16% as of June 2026. That compares with -10.22% in the prior-year period — down 185.3% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Sanara MedTech's historical trend and sector peers before judging valuation or financial health.

Over the past year, SMTI's profit margin moved from -10.22% to -29.16% — a 185.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sanara MedTech's valuation or profitability profile.

Against Healthcare companies, SMTI currently prints -29.16% for profit margin, while the sector average sits near 14.34%. That is roughly 303.3% below the sector mean. Large gaps often invite a closer look at Sanara MedTech's growth, margins, and balance sheet.

Profit Margin shows how effectively Sanara MedTech converts resources into returns. At -29.16%, SMTI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -10.22% in the prior-year period — down 185.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SMTI's profit margin (-29.16%), review year-over-year change from -10.22%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.